» Authors » Monika Adamczyk-Sowa

Monika Adamczyk-Sowa

Explore the profile of Monika Adamczyk-Sowa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 108
Citations 508
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosciszewska-Zukowska I, Kulakowska A, Kalinowska A, Bartosik-Psujek H, Mirowska-Guzel D, Stasiolek M, et al.
Neurol Neurochir Pol . 2025 Jan; 59(1):20-32. PMID: 39811975
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) that is usually diagnosed between the ages of 20 and 40. Changes in the immune system...
2.
Mirowska-Guzel D, Nojszewska M, Jaroszewicz J, Kalinowska A, Kulakowska A, Ledwoch J, et al.
Neurol Neurochir Pol . 2025 Jan; 59(1):1-5. PMID: 39807949
A working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society, the Polish Society of Family Medicine, and the Polish Society of Vaccinology has...
3.
Kulakowska A, Mirowska-Guzel D, Kalinowska A, Bartosik-Psujek H, Brola W, Stasiolek M, et al.
Neurol Neurochir Pol . 2024 Dec; 58(6):569-585. PMID: 39737584
The treatment of multiple sclerosis (MS) has undergone significant changes since the first disease-modifying therapy (DMT) drug was introduced. Currently, 19 original DMT drugs are registered in the European Union....
4.
Lis M, Niedziela N, Adamczyk-Zostawa J, Zalejska-Fiolka J, Szczygiel J, Sowa A, et al.
Curr Issues Mol Biol . 2024 Dec; 46(12):14119-14131. PMID: 39727973
Studies suggest that vitamin D (VitD) may reduce oxidative stress (OS) in multiple sclerosis (MS) patients. This study aimed to compare the effects of various VitD doses on OS in...
5.
Zakrzewska-Pniewska B, Bartosik-Psujek H, Brola W, Golebiowski M, Kalinowska A, Kulakowska A, et al.
Neurol Neurochir Pol . 2024 Dec; 59(1):6-19. PMID: 39692818
Introduction: An expert panel of the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society has developed principles for the management of neuromyelitis optica spectrum disorders (NMOSD). These...
6.
Mado H, Stasiniewicz A, Adamczyk-Sowa M, Sowa P
Int J Mol Sci . 2024 Oct; 25(20). PMID: 39456713
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that progresses with demyelination and neurodegeneration. To date, many studies have revealed the key role of...
7.
Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiolek M, Niedziela J, Czuba Z, et al.
Int J Mol Sci . 2024 Oct; 25(19). PMID: 39408830
Permanent inflammatory demyelinating and neurodegenerative processes lead to neurological disability in patients with multiple sclerosis (MS). The anti-inflammatory properties of vitamin D (VitD) are well established, but its role in...
8.
Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiolek M, Zalejska-Fiolka J, Czuba Z, et al.
Diagnostics (Basel) . 2024 Sep; 14(17). PMID: 39272777
Background: Inflammatory demyelination and impaired recovery processes result in permanent neurodegeneration and neurological disability in patients with multiple sclerosis (MS). In terms of smoldering MS, chronic neuroinflammation develops in the...
9.
Gebka-Kepinska B, Adamczyk B, Adamczyk J, Czuba Z, Gebka-Adamczyk N, Szczygiel J, et al.
Mult Scler Relat Disord . 2024 Aug; 90:105800. PMID: 39197352
Objectives: Multiple sclerosis (MS) is a chronic CNS autoimmune disease characterized by demyelination and neurodegeneration. Chemokines regulate leukocyte migration and inflammation in MS. In the present study, we evaluated selected...
10.
Lis M, Niedziela N, Adamczyk-Zostawa J, Zalejska-Fiolka J, Blachut M, Szczygiel J, et al.
Int J Mol Sci . 2024 Jul; 25(14). PMID: 39062835
There is increasing evidence that vitamin D (VitD) supplementation may reduce inflammation in individuals with multiple sclerosis (MS). The aim of this study was to evaluate the effect of different...